Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pablo Berlanga

Showing results (1-10 of 72) with videos related to

Pageof 8
Sort By:
Expert Opinion on Emerging Drugs|March 4, 2017
Advances in emerging drugs for the treatment of neuroblastomaPablo Berlanga, Adela Cañete, Victoria Castel
Expert Opinion on Emerging Drugs|May 23, 2013
Emerging drugs for neuroblastomaVictoria Castel, Vanessa Segura, Pablo Berlanga
Current Opinion in Oncology|May 22, 2024
Emerging therapies in Ewing sarcomaSandra J Strauss, Pablo Berlanga, Martin G McCabe
Anales De Pediatria (Barcelona, Spain : 2003)|April 13, 2016
[Medulloblastoma: improved survival in recent decades. Unicentric experience]Lucía Igual Estellés, Pablo Berlanga Charriel, Adela Cañete Nieto
Journal of Pediatric Hematology/Oncology|March 2, 2016
Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution ExperiencePablo Berlanga, Adela Cañete, Marta Salom, et al.
Faculty Reviews|March 4, 2021
Recent advances in understanding osteosarcoma and emerging therapiesNathalie Gaspar, Maria Eugenia Marques da Costa, Olivia Fromigue, et al.
Frontiers in Endocrinology|August 2, 2021
Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case ReportGiulia Del Sindaco, Pablo Berlanga, Laurence Brugières, et al.
Journal of Pediatric Hematology/Oncology|November 7, 2014
Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution ExperiencePablo Berlanga, Adela Cañete, Roberto Díaz, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|June 4, 2016
[Current situation on fertility preservation in cancer patients in Spain: Level of knowledge, information, and professional involvement]Carmen Garrido-Colino, Alvaro Lassaletta, María Ángeles Vazquez, et al.
Pediatric Blood & Cancer|October 15, 2024
Rationale for irradiation of persisting oligo-skeletal metastases to improve survival of metastatic neuroblastoma patients with a poor response to chemotherapy: A retrospective studyLea Rossillon, Véronique Edeline, Laurentiu Agrigoroaie, et al.
Pageof 8

Showing results (1-10 of 72) with videos related to

Sort By:
Pageof 8
Expert Opinion on Emerging Drugs|March 4, 2017
Advances in emerging drugs for the treatment of neuroblastomaPablo Berlanga, Adela Cañete, Victoria Castel
Expert Opinion on Emerging Drugs|May 23, 2013
Emerging drugs for neuroblastomaVictoria Castel, Vanessa Segura, Pablo Berlanga
Current Opinion in Oncology|May 22, 2024
Emerging therapies in Ewing sarcomaSandra J Strauss, Pablo Berlanga, Martin G McCabe
Anales De Pediatria (Barcelona, Spain : 2003)|April 13, 2016
[Medulloblastoma: improved survival in recent decades. Unicentric experience]Lucía Igual Estellés, Pablo Berlanga Charriel, Adela Cañete Nieto
Journal of Pediatric Hematology/Oncology|March 2, 2016
Postrelapse Prognostic Factors in Nonmetastatic Osteosarcoma: A Single-institution ExperiencePablo Berlanga, Adela Cañete, Marta Salom, et al.
Faculty Reviews|March 4, 2021
Recent advances in understanding osteosarcoma and emerging therapiesNathalie Gaspar, Maria Eugenia Marques da Costa, Olivia Fromigue, et al.
Frontiers in Endocrinology|August 2, 2021
Mineral and Bone Consequences of High Dose Denosumab Therapy to Treat an Aneurysmal Bone Cyst, a Child Case ReportGiulia Del Sindaco, Pablo Berlanga, Laurence Brugières, et al.
Journal of Pediatric Hematology/Oncology|November 7, 2014
Presentation and Long-term Outcome of High-grade Osteosarcoma: A Single-institution ExperiencePablo Berlanga, Adela Cañete, Roberto Díaz, et al.
Anales De Pediatria (Barcelona, Spain : 2003)|June 4, 2016
[Current situation on fertility preservation in cancer patients in Spain: Level of knowledge, information, and professional involvement]Carmen Garrido-Colino, Alvaro Lassaletta, María Ángeles Vazquez, et al.
Pediatric Blood & Cancer|October 15, 2024
Rationale for irradiation of persisting oligo-skeletal metastases to improve survival of metastatic neuroblastoma patients with a poor response to chemotherapy: A retrospective studyLea Rossillon, Véronique Edeline, Laurentiu Agrigoroaie, et al.
Pageof 8